Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
7.64 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.64 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.64 | 17418594 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.88 | 6695378 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
5.13 | 21441931 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.73 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
4.15 | 16206674 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.57 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.26 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.19 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.19 | 17369602 16595493 16096432 16115903 18695136 15668708 15939500 15692762 16264153 15994142 19526202 18382427 18628466 15634643 15136595 16322301 15567936 15993339 17426702 17983394 16935488 16826403 11325840 18234424 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.86 | 11589617 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.68 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.36 | 15553829 16217749 11135700 14691202 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.36 | 18059187 16234567 16023760 17876044 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.74 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.33 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.57 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
5.03 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
5.03 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.80 | 16731534 17974986 15476868 15792986 18627295 16455267 16269455 17007740 17351982 17382496 15505089 16952015 16109756 17924179 17329180 16278810 17308081 17928571 16651473 16612575 17131338 16242529 16364871 15811867 17519947 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.06 | 16243910 17334414 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.67 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.67 | 18802399 18259882 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.77 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.89 | 10525206 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.63 | 15213294 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.53 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.99 | 18602426 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.72 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
6.02 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.73 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.73 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.77 | 15073043 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.33 | 19069698 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.85 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.61 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.81 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.85 | 20471113 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.78 | 17875725 12587719 16495754 18674790 16244372 16144979 18006777 17888722 16879835 16244371 14766674 16707910 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.59 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.38 | 15692506 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.82 | 15147373 17606976 18501091 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.28 | 15699352 16775033 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.64 | 16707910 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
3.01 | 15070760 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
6.02 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.28 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
5.05 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.75 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
4.24 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.19 | 16467208 16968895 17050201 20471514 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.48 | 17712046 17869043 17107899 12679006 17649720 15336539 16891316 16330433 12712474 16966277 19642359 17217047 11468182 12018890 16112521 16331271 16823087 15748426 19075265 15622746 15213294 19225113 19035177 11161223 9834237 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.94 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.16 | 16439617 16595196 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
5.00 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
5.00 | 21137059 20195826 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.99 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.99 | 17085340 16842330 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.69 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.69 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.69 | 20464547 18569708 17053015 18816296 20869020 18520028 20135361 6695378 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.69 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.77 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.18 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
5.22 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.29 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.33 | 16827129 |
OMIM:300220 |
MENTAL RETARDATION, X-LINKED, SYNDROMIC 10 |
marker/mechanism |
|
| |
OMIM:300706 |
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE |
marker/mechanism |
|
| |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.20 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.98 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.53 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.53 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.41 | 14977855 19417148 19549372 15949261 11468182 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.54 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.36 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.09 | 19429709 15857846 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.54 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.09 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.35 | 11141357 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.42 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.42 | 16889571 15640375 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.38 | 10525206 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.45 | 15555623 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.48 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.51 | 19769630 16624393 12452020 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.64 | 15580305 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.69 | 19927285 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
6.02 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
6.02 | 17638057 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.51 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.51 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.51 | 16888761 16729912 15749863 18437689 16868541 15897917 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.87 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.44 | 17710206 16767912 15675481 15625365 17203757 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
12.29 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
12.29 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.53 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
6.39 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.39 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
5.22 | 17203757 16767912 15625365 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.45 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.45 | 20155912 2093021 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
8.49 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
8.49 | 17909728 16010429 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.70 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
9.18 | 12845720 20435036 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
9.18 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
9.18 | 17653716 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.87 | 17334414 17638931 17678736 16364871 |